In terms of government regulation of the pharmaceutical industry, almost two-thirds (65%) say there should be more regulation limiting the price of prescription drugs, and about half say there should be more regulation of drug advertising (51%) and drug safety (50%). These shares have increased since 2000 when just over one-third said there should be more regulation of drug advertising (37%) and drug safety (36%) (data not shown).

In comparison, 14% say there is currently the right amount of government regulation of prescription drug prices, but many more are satisfied with regulation of drug advertising (39% say “right amount”) and drug safety (39%).